Follow
Jafar Sadik Bhasha Shaik, Ph.D.
Jafar Sadik Bhasha Shaik, Ph.D.
Verified email at its.jnj.com
Title
Cited by
Cited by
Year
Synthesis and antimycobacterial evaluation of various 7-substituted ciprofloxacin derivatives
D Sriram, P Yogeeswari, JS Basha, DR Radha, V Nagaraja
Bioorganic and medicinal chemistry 13 (20), 5774 - 5778, 2005
1592005
Analysis of five HMG‐CoA reductase inhibitors—atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and …
MK Pasha, S Muzeeb, SJS Basha, D Shashikumar, R Mullangi, ...
Biomedical Chromatography 20 (3), 282-293, 2006
1492006
Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: quantitative application to various in vitro metabolic stability studies and …
SJS Basha, SA Naveed, NK Tiwari, D Shashikumar, S Muzeeb, TR Kumar, ...
Journal of Chromatography B 853 (1-2), 88-96, 2007
612007
Evaluation of glycolamide esters of indomethacin as potential cyclooxygenase-2 (COX-2) inhibitors
S Khanna, M Madan, A Vangoori, R Banerjee, R Thaimattam, ...
Bioorganic Medicinal Chemistry 14 (14), 4820 - 4833, 2006
552006
Soluble epoxide hydrolase inhibitor trans-4-[4-(3-adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid is neuroprotective in rat model of ischemic stroke
JSB Shaik, M Ahmad, W Li, ME Rose, LM Foley, TK Hitchens, SH Graham, ...
American journal of physiology: Heart and circulatory physiology 305 (11 …, 2013
542013
Vascular characterization of mice with endothelial expression of cytochrome P450 4F2
J Cheng, ML Edin, SL Hoopes, H Li, JA Bradbury, JP Graves, LM DeGraff, ...
FASEB J 28 (7), 2915 - 2931, 2014
492014
Rapid and simultaneous quantitation of prostanoids by UPLC-MS/MS in rat brain
SB Shaik, M TM, P SM, SH Graham, MD Manole
Journal of chromatography. B, Analytical technologies in the biomedical and …, 2014
392014
20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac …
JS Shaik, SM Poloyac, PM Kochanek, H Alexander, DL Tudorascu, ...
Journal of cerebral blood flow and metabolism 35 (11), 1757–1763, 2015
362015
A phase 1 study to evaluate the pharmacokinetics and safety of cabotegravir in patients with hepatic impairment and healthy matched controls
JSB Shaik, SL Ford, Y Lou, Z Zhang, KK Bakshi, AR Tenorio, C Trezza, ...
Clinical pharmacology in drug development 8 (5), 664-673, 2019
232019
Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers
BM Jucker, EJ Fuchs, S Lee, V Damian, P Galette, R Janiczek, KJ Macura, ...
British Journal of Clinical Pharmacology 88 (4), 1655-1666, 2022
202022
Pharmacokinetics and antiviral activity of cabotegravir and rilpivirine in cerebrospinal fluid following long-acting injectable administration in HIV-infected adults
SL Letendre, A Mills, D Hagins, S Swindells, F Felizarta, J Devente, ...
Journal of Antimicrobial Chemotherapy 75 (3), 648-655, 2020
202020
Multicompartmental pharmacokinetic evaluation of long‐acting cabotegravir in healthy adults for HIV preexposure prophylaxis
JS Shaik, ED Weld, S Edick, E Fuchs, S Riddler, MA Marzinke, R D'Amico, ...
British journal of clinical pharmacology 88 (4), 1667-1678, 2022
132022
Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats
S Muzeeb, MK Pasha, SJS Basha, R Mullangi, NR Srinivas
Xenobiotica 35 (8), 825-838, 2005
132005
Pharmacokinetics and tolerability of cabotegravir and rilpivirine long-acting intramuscular injections to the vastus lateralis (lateral thigh) muscles of healthy adult …
K Han, H Gevorkyan, J Sadik Shaik, H Crauwels, C Leemereise, ...
Antimicrobial Agents and Chemotherapy 68 (1), e00781-23, 2024
92024
First in human study with GSK3359609 [GSK609], inducible T cell co-stimulator (ICOS) receptor agonist in patients [Pts] with advanced, solid tumors: Preliminary results from …
A Hansen, TM Bauer, V Moreno, M Maio, S Groenland, J Martin-Liberal, ...
Annals of Oncology 29, viii404, 2018
72018
Comparison between physiologically based pharmacokinetic and population pharmacokinetic modelling to select paediatric doses of gepotidacin in plague
D Nguyen, JS Shaik, G Tai, C Tiffany, C Perry, E Dumont, D Gardiner, ...
British Journal of Clinical Pharmacology 88 (2), 416-428, 2022
62022
Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP …
S Muzeeb, SJS Basha, D Shashikumar, R Mullangi, NR Srinivas
European journal of drug metabolism and pharmacokinetics 31, 299-309, 2006
52006
Distribution in Cerebrospinal Fluid (CSF) of Cabotegravir (CAB) and Rilpivirine (RPV) after intramuscular administration of long-acting (LA) injectable suspensions in HIV-1 …
S Letendre, A Mills, D Hagins, S Swindells, F Felizarta, J DeVente, ...
J Int AIDS Soc 21 (Suppl 8), 2018
42018
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade
S Yadavilli, JD Waight, S Brett, M Bi, T Zhang, YB Liu, C Ellis, DC Turner, ...
Cancer Research Communications 3 (8), 1564-1579, 2023
32023
A study evaluating the safety, tolerability, and pharmacokinetics of a high-concentration (CAB 400 mg/ml) cabotegravir long-acting injectable formulation following subcutaneous …
P Benn, K Han, J Sievers, JS Shaik, M Warwick-Sanders, B Win, D Dorey, ...
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 25, 125-126, 2022
32022
The system can't perform the operation now. Try again later.
Articles 1–20